Carnegie Mellon and Yale Study in Mice Shows Promise for Treating Genetic Conditions During Early Stages of Development
Researchers at Carnegie Mellon University and Yale University have for the first time used a gene editing technique to successfully cure a genetic condition in utero in a mouse model. Their findings, published in Nature Communications, present a promising new avenue for research into treating genetic conditions during fetal development.
An estimated 8 million children are born each year with severe genetic disorders or birth defects. Genetic conditions can often be detected during pregnancy using amniocentesis, but there are no treatment options to correct these genetic conditions before birth.
“Early in embryonic development, there are a lot of stem cells dividing at a rapid pace. If we can go in and correct a genetic mutation early on, we could dramatically reduce the impact the mutation has on fetal development or even cure the condition,” said Danith Ly, professor of chemistry in Carnegie Mellon’s Mellon College of Science.
In this study, the researchers used a peptide nucleic acid-based gene editing technique that they had previously used to cure beta thalassemia, a genetic blood disorder that results in the reduced production of hemoglobin, in adult mice.
Peptide nucleic acids are synthetic molecules that combine a synthetic protein backbone with the nucleobases found in DNA and RNA. The PNAs used in this study were created by Ly at Carnegie Mellon’s Center for Nucleic Acids Science and Technology (CNAST), a leading center for PNA science.
Their technique uses an FDA-approved nanoparticle to deliver PNA molecules paired with donor DNA to the site of a genetic mutation. When the PNA-DNA complex identifies a designated mutation, the PNA molecule binds to the DNA and unzips its two strands. The donor DNA binds with the faulty DNA and spurs the cell’s DNA repair pathways into action, allowing it to correct the error.
In the current study, the researchers used a technique similar to amniocentesis to inject the PNA complex into the amniotic fluid of pregnant mice whose fetuses carried a mutation in the beta-globin gene that causes beta thalassemia.
With just one injection of the PNA during gestation, the researchers were able to correct 6 percent of the mutations. This 6 percent correction was enough to cause dramatic improvements in the mice’s symptoms of beta thalassemia – and enough for the mice to be considered cured. Mice that were treated using PNA while in utero had levels of hemoglobin that were within the normal range, less spleen enlargement and increased survival rates.
The researchers also noted that there were no off-target effects from the treatment, a finding that might suggest this method would be preferable over other gene editing techniques like CRISPR/Cas9, which can erroneously damage off-target DNA.
“CRISPR is much easier to use, which makes it ideal for laboratory research. But the off-site errors make it less useful for therapeutics,” said Ly. “The PNA technique is more ideal for therapeutics. It doesn’t cut the DNA, it just binds to it and repairs things that seem unusual. We looked at 50 million samples and couldn’t find one offsite error when we used our PNA gene editing technique.”
The researchers believe that their technique might be able to achieve even higher success rates if they can administer it multiple times during gestation. They also hope to see if their technique can be applied to other conditions .
The Latest on: Curing a genetic condition in utero
via Google News
The Latest on: Curing a genetic condition in utero
- Treatment in the womb could cure genetic condition on February 18, 2019 at 4:39 pm
A gene-editing treatment could fix a devastating genetic condition while a child is still in the womb. Children with Angelman syndrome are born with severe intellectual and physical disabilities which ... […]
- Gene therapy could treat rare brain disorder in unborn babies on February 18, 2019 at 2:00 pm
Doctors believe that for neurodevelopmental disorders, the best time ... a radical form of gene therapy that could cure a devastating medical disorder by mending mutations in the brains of foetuses in ... […]
- Is a cure for blindness in sight? Scientists launch first attempt to halt most common cause of age-related blindness with gene therapy on February 18, 2019 at 6:36 am
A team from Oxford University has for the last 12 years been experimenting with gene therapies to slow or halt the progress of different eye conditions ... blindness in the developed world. ‘A genetic ... […]
- Her unborn baby had a birth defect — so doctors performed surgery inside her womb on February 13, 2019 at 10:26 am
During the operation, surgeons in London would cut open Simpson’s womb, repair the ... said fetal surgery is not a cure for spina bifida but that it has been shown to dramatically improve the outcome ... […]
- Life in the Womb Can Program Future Heart Disease on February 7, 2019 at 1:24 pm
Therefore, these studies highlight a disproportionate risk of disease in offspring born from the same mother but under different in utero conditions ... and is in no way intended to diagnose, cure, or ... […]
- Treating Genetic Diseases in Utero Could Change the CRISPR Space on October 14, 2018 at 11:34 am
but there is one major overlooked advantage in developing treatments for this disease group over others. Genetic diseases can be screened for in utero. So what? Thanks to new research published in the ... […]
- Prenatal gene editing success lays path for treating congenital diseases in the womb on October 8, 2018 at 5:35 pm
In this particular experiment the fetus was not treated while it was in the womb. In order to ensure accurate ... breakthrough is a major step forward in finding a cure for a large number of genetic d... […]
- In Utero Gene Editing Technique Developed At CMU And Yale Could Be Used In Humans on August 2, 2018 at 2:19 pm
A study by Carnegie Mellon University and Yale University has found a gene editing technique administered in fetal mice can cure a genetic blood disease before birth. This is the first time this techn... […]
- Gene editing technique can treat thalassemia in womb on July 11, 2018 at 1:35 am
Mice treated using PNA while in utero showed levels ... If we can go in and correct a genetic mutation early on, we could dramatically reduce the impact the mutation has on foetal development or even ... […]
- Gene Editing Technique Cures Genetic Disorder in Utero on July 10, 2018 at 7:52 am
Researchers have used a gene editing technique to successfully cure a genetic condition in a mouse model ... Mice that were treated using PNA while in utero had levels of hemoglobin that were within t... […]
via Bing News